Antibodies that could help develop a vaccine for HIV
George Georgiou, a professor of engineering and molecular biosciences at the University of Texas at Austin, and his colleagues have developed a hybrid antibody that neutralized 99 percent of HIV-1 strains tested. The antibody is based on so-called “broadly-neutralizing antibodies,” a group of antibodies from HIV-infected patients that are able to take down an array of rapidly mutating HIV-1 viruses.
The research was published last week in the journal Science Immunology.
https://cns.utexas.edu/news/hybrid-antibody-takes-down-hiv
https://news.utexas.edu/2016/11/15/new-findings-on-flu-vaccines-effectiveness
